Overview Performance Portfolio Dividends Charges Gearing Research Announcements Management Documents Invest

Top holdings

Data as at : 30/06/2025

Investment % of total assets
Geron Corporation (USA) 13.3
Lineage Cell Therapeutics (USA) 0.2
Relief Therapeutics 0.1
Angle 0.1
Proteome Science 0.0
Regent Pacific 0.0
Northwest Biotherapeutics (USA) 0.0
Sherborne Invs (Gurnsey) B 0.0
Sarossa Capital 0.0

Geographic breakdown

Data as at : 30/06/2024

Country % of total assets
United States 61.3
United Kingdom 15.4
Germany 0.1

Depending on the nature of the underlying asset classes, geographic breakdowns may not always add up to 100%.

Industry breakdown

Data as at : 30/06/2024

Industry % of total assets
Cash Equivalents 63.4
Healthcare 61.3
Financial Services 15.4
Scroll

Asset breakdown

Data as at : 30/06/2024

Asset % of total assets
Stock 77.3
Other -40.7
Cash/Cash equivalents 63.4

Detailed asset breakdown

Data as at : 30/06/2024

Asset % of total assets
Cash 63.4
North America - stock 61.3
Other - stock 15.9

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.